Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. It has been revealed recently that bile acids also function as signaling molecules for regulating bile acid metabolism and cholesterol homeostasis (1). A major advance toward understanding the molecular mechanism of bile acid-induced negative feedback regulation of the genes involved in bile acid synthesis has come with the identification of the small heterodimer partner (SHP) 1 as a negative nuclear receptor induced by the farnesoid X receptor, a nuclear receptor of bile acids (2, 3). SHP lacks the highly conserved DNA-binding domain present in other members of the nuclear receptor superfamily (4), and it interacts with a variety of nuclear receptors, including the thyroid hormone receptor (4), the retinoic acid receptor (4), peroxisome proliferator-activated receptor-␣ (5), the retinoid X receptor (6), estrogen receptor-␣ (7, 8), the pregnane X receptor (9), hepatocyte nuclear factor-4 (HNF-4) (10), and the liver receptor homolog that activates the transcription of cholesterol 7␣-hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid biosynthesis (2, 3).Angiotensinogen (ANG), the precursor of vasoactive octapeptide angiotensin II, is mainly synthesized in the liver and secreted into the circulation (11). We have identified various regulatory elements and factors that regulate human ANG gene transcription (12-19). Our previous studies have shown that cis-acting elements located at nucleotides Ϫ1222 to ϩ44 are sufficient for human ANG gene expression in transiently transfected human hepatoma HepG2 cells and in the livers of transgenic mice (20,21) and that HNF-4 plays an important role in hepatic ANG expression (18). The human ANG transgenic mouse exhibits high blood pressure through cross-mating with the line expressing human renin (22).It has been shown that bile duct ligation in animals, an experimental model of liver cirrhosis, results in a decrease in blood pressure and a transient decrease in plasma ANG despite an increase in plasma renin activity (23-25). Interestingly, hepatorenal syndrome, a disease with acute renal failure induced by severe hepatic diseases, is thought to result from the disruption of vasoactive factor control, but its mechanism is ill defined. In hepatorenal syndrome, arterial vasodilation occurs despite high plasma renin activity (26). These observations prompted us to investigate the effect of